PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it will present at the Merriman Curhan Ford 5th Annual Investor Summit 2008 to be held in San Francisco, September 15-16 at the Mark Hopkins InterContinental Hotel.
